Physician profile
Muhammad Abdullah
NPI 1265446405
$12,544.25
in general payments reported to CMS, 2019-2025
53 companies · $1,667 in 2025
The $1,667 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,106 · 2020: $1,473 · 2021: $1,567 · 2022: $1,725 · 2023: $2,099 · 2024: $1,907 · 2025: $1,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,632 · Education: $41.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,632.11 |
| Education | $41.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,525.63 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $1,214.12 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,199.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,032.62 | 2019-2025 | Jardiance, Synjardy |
| Amgen INC. | $836.77 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $822.19 | 2019-2025 | Vraylar, Durysta, Linzess |
| Merck Sharp & Dohme LLC | $814.26 | 2019-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $746.92 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $697.01 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $365.92 | 2019-2025 | Xifaxan, Trulance |
| Ardelyx, INC. | $301.33 | 2024-2025 | Ibsrela |
| Edwards Lifesciences Corporation | $259.71 | 2022 | |
| Redhill Biopharma INC. | $220.93 | 2020-2024 | Talicia, Aemcolo, Movantik |
| Janssen Pharmaceuticals, INC | $203.39 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $193.87 | 2021-2025 | Zoryve |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $181.51 | 2019-2025 | |
| Exact Sciences Corporation | $169.34 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $134.30 | 2021-2023 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $129.03 | 2019-2025 | Austedo Xr |
| Medtronic, INC. | $118.18 | 2023 | Ellipsys Vascular Access System |
| Novartis Pharmaceuticals Corporation | $104.67 | 2021-2023 | |
| Sanofi Pasteur INC. | $99.11 | 2019-2025 | |
| Alkermes, INC. | $91.28 | 2024-2025 | Aristada, Vivitrol, Lybalvi |
| Horizon Therapeutics Plc | $84.78 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $81.06 | 2021-2024 | Eliquis |
| Eisai INC. | $71.05 | 2020-2022 | |
| Allergan, INC. | $71.03 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $70.72 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Genentech USA, INC. | $68.09 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.53 | 2019 | |
| Esperion Therapeutics, INC. | $50.97 | 2024-2025 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $44.87 | 2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $41.93 | 2023-2024 | |
| Amarin Pharma, INC. | $40.43 | 2019-2022 | |
| Janssen Biotech, INC. | $32.27 | 2022-2023 | Stelara |
| Viiv Healthcare Company | $31.90 | 2023 | Apretude |
| Mannkind Corporation | $30.90 | 2020-2023 | Afrezza |
| Phadia US INC. | $30.90 | 2019-2025 | Immunocap |
| Nestle Healthcare Nutrition INC. | $30.11 | 2021-2022 | |
| Intra-Sana Laboratories | $29.66 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Vertical Pharmaceuticals, LLC | $23.33 | 2019-2020 | |
| Linus Health, INC. | $20.19 | 2023 | |
| Renalytix Ai, INC. | $19.01 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Qiagen, LLC | $18.92 | 2021 | |
| Validus Pharmaceuticals LLC | $18.64 | 2025 | Lopressor |
| Ibsa Pharma INC. | $18.32 | 2025 | Tirosint, Licart, Flector |
| Abiomed | $17.73 | 2025 | |
| Phathom Pharmaceuticals, INC. | $15.10 | 2024 | Voquezna |
| Mylan Specialty L.P. | $14.82 | 2019 | |
| Radius Health, INC. | $13.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.27 | 2020 | |
| Ironwood Pharmaceuticals, INC | $12.20 | 2019 | |
| Dermira, INC. | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.